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The hemagglutinin (H) protein of measles virus (MV) mediates attachment to cellular receptors. The ectodomain
of the H spike is thought to consist of a membrane-proximal stalk and terminal globular head, in which resides the
receptor-binding activity. Like other paramyxovirus attachment proteins, MV H also plays a role in fusion promo-
tion, which is mediated through an interaction with the viral fusion (F) protein. The stalk of the hemagglutinin-
neuraminidase (HN) protein of several paramyxoviruses determines specificity for the homologous F protein. In
addition, mutations in a conserved domain in the Newcastle disease virus (NDV)HN stalk result in a sharp decrease
in fusion and an impaired ability to interact with NDV F in a cell surface coimmunoprecipitation (co-IP) assay. The
region ofMVH that determines specificity for the F protein has not been identified. Here, we have adapted the co-IP
assay to detect the MV H-F complex at the surface of transfected HeLa cells. We have also identified mutations in
a domain in the MV H stalk, similar to the one in the NDV HN stalk, that also drastically reduce fusion yet do not
block complex formation withMVF. These results indicate that this domain in theMVH stalk is required for fusion
but suggest either that mutation of it indirectly affects the H-dependent activation of F or that the MV H-F
interaction is mediated by more than one domain in H. This points to an apparent difference in the way the MV and
NDV glycoproteins interact to regulate fusion.
Measles virus (MV) is the only human pathogen of the Mor-
billivirus genus in the family Paramyxoviridae (17). Paramyxovi-
ruses, like other enveloped viruses, enter cells by fusing their lipid
membranes with those of target host cells (23). The membrane
fusion process is brought about by interactions between cellular
receptors and viral glycoproteins (22). The surfaces of measles
virions and infected cells contain two types of viral transmem-
brane glycoproteins, the hemagglutinin (H) and fusion (F) pro-
teins (17). MV H binds to cellular protein receptors, either CD46
or CD150 (11, 14, 34), and is an important determinant of viral
tropism (49). MV F, with a contribution from the H protein,
mediates virion-to-cell and cell-to-cell membrane fusion (48).
The MV H protein is a type II glycoprotein believed to exist
as a tetramer composed of a pair of dimers, in which the
monomers are disulfide linked. MV H has a short N-terminal
cytoplasmic tail followed by a transmembrane domain and a
large C-terminal ectodomain (1). It is believed that the ectodo-
main consists of a stalk region that supports a globular domain
containing the receptor recognition and antigenic regions of
the protein (24).
MV glycoprotein-promoted membrane fusion is thought to
involve a series of conformational changes in the F protein
from a metastable prefusion state to a highly stable postfusion
state (38). These changes occur at neutral pH at the surface of
the target membrane and are believed to be triggered by re-
ceptor recognition by the H protein. In addition to bringing the
two membranes into close proximity prior to F activation, there
is evidence that MV H is involved in triggering F activation
through a specific interaction between the two proteins. First,
expression of both MV H and F is required for membrane
fusion (48). Second, although the H glycoproteins of MV and
canine distemper virus (CDV) are, to a certain extent, inter-
changeable, fusion promotion is most efficient when the H and
F proteins are derived from the same virus and strain (3, 5, 40,
44, 47). Third, monoclonal antibodies (MAbs) to MV H that
block infectivity and inhibit fusion without interfering with
receptor binding have been characterized previously (15, 19).
The exact mechanism by which MV H receptor recognition
triggers the conformational changes in F remains unknown.
Based on the requirement for expression of MV or CDV glyco-
proteins from the same virus and strain for maximum fusion
efficiency, it has been suggested that fusion promotion requires a
physical interaction between specific domains of the proteins (5,
44). Indeed, a heterooligomeric interaction between MV H and F
in the endoplasmic reticulum has been detected and is proposed
to play an integral role in regulating fusion (36).
While multiple regions of both H and F have been implicated
in fusion promotion, it has not been established which domains
on the two proteins directly mediate the interaction between
them. In addition to the residues that mediate receptor binding,
there are two regions of MV H that have been suggested to have
a role in fusion promotion. Region 244 to 250 has been identified
as a linear epitope in the globular region recognized by an MAb
that inhibits syncytium formation but not receptor recognition
(15). Based on this, it was suggested that the region constitutes
either a functional or a physical interface between MV H and F.
However, this was not tested directly and it remains possible that
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the MAb blocks fusion by an indirect mechanism, such as pre-
vention of conformational changes in MV H that are integral to
the fusion process.
Additionally, a mutation at residue I98 in the MV H stalk
was found to be responsible for the lack of syncytium forma-
tion in a persistently infected cell line (20). Examination of the
sequence surrounding this residue reveals a motif, spanning
the region I84 to L105, which, analogous to a corresponding
domain in the Newcastle disease virus (NDV) hemagglutinin-
neuraminidase protein (HN) stalk (41), possesses some prop-
erties of a heptad repeat (HR). In this region, every seventh
residue is hydrophobic; however, unlike a true HR, the resi-
dues in the fourth (or d) positions are not hydrophobic. The
domain in NDV HN has, nonetheless, been termed an HR
(41). This region in MV H is of potential interest because
mutations in the corresponding domain in the NDV HN pro-
tein interfere with both fusion and the interaction with F, as
detected in a coimmunoprecipitation (co-IP) assay (27, 28).
Mutations in NDV HN that reduced fusion activity to less than
20% of that of the wild-type (wt) protein could not be detected
in a complex with NDV F at the cell surface. This raises the
possibility that mutation of I98 in the MV H protein may also
interfere with fusion by disrupting the H-F interaction.
To further explore the roles of regions 244 to 250 and 84 to
105 in MV H function, we have performed site-directed mu-
tational analyses of these two regions and determined the
effects on several aspects of the fusion process. On the one
hand, alanine-scanning mutagenesis does not support the idea
that the region 244 to 250 constitutes a functional interface
between H and F. Mutation of residues in this region does not
significantly alter either receptor binding or fusion promotion
by MV H. On the other hand, several site-directed mutations
in the stalk of MV H do modulate hemadsorption (HAd)
activity. This suggests that changes in the HR-like domain can
alter the structure and/or orientation of the globular head
domain. More importantly, several mutations in the HR-like
domain specifically decrease fusion with no discernible effect
on attachment, consistent with the region playing a role in
mediating the fusion helper activity of MV H. However, these
mutations do not abolish the H-F interaction at the cell sur-
face, as detected by a cell surface co-IP assay. Thus, either the
domain is not directly involved in mediating the interaction
with F or the interaction is mediated by more than one domain.
MATERIALS AND METHODS
Recombinant plasmids and site-directed mutagenesis. The H and F genes of
the Edmonston MV strain were gifts of Michael Oldstone (The Scripps Research
Institute). MV H was released from the vector in which it was supplied by SacII
digestion, and MV F was released by XhoI/SacII digestion. Both genes were
ligated into the pBluescript SK() (pBSK) expression vector (Stratagene, La
Jolla, CA). The H and F genes of the Ondersterpoort CDV strain were gifts of
Shmuel Rozenblatt (Tel Aviv University). Both genes were released from the
vectors in which they were provided by NcoI/StuI digestion and ligated into
pBSK at the same sites, previously added by mutagenesis.
Site-directed mutagenesis was performed as described previously (6). Briefly,
a single-stranded DNA template was rescued by R408 helper phage (Stratagene,
La Jolla, CA) in CJ236 cells. Mutagenesis primers (Integrated DNA Technolo-
gies, Coralville, IA) were annealed to the template and extended with T4 DNA
polymerase, and the ends were ligated with T4 DNA ligase (Roche). The mu-
tagenesis reaction products were transformed into MV1190 cells (Bio-Rad, Her-
cules, CA) that were then selected for ampicillin resistance. Identification of
colonies carrying mutated genes was facilitated by screening for the presence of
a unique restriction site introduced by each mutagenic primer. Multiple clones
were characterized for each mutant DNA, and the presence of the desired
mutation was confirmed by DNA sequencing.
Antibodies. Polyclonal antiserum (Fcyt) to a peptide mimicking a region in the
cytoplasmic tail of MV F (4) was initially a gift of Roberto Cattaneo and was later
prepared (Proteintech Group, Inc., Chicago, IL). A mixture of two MAbs to the
MV H protein was purchased commercially (Chemicon, Temicula, CA). A hy-
bridoma producing another anti-H MAb, called B2, was a gift of Paul Rota. The
MAbs recognize both native and denatured H.
Transient expression. HeLa cells were maintained in Dulbecco’s modified
Eagle medium (DMEM) with high glucose, L-glutamine, and pyridoxine hydro-
chloride supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, 0.1
mM MEM nonessential amino acid solution, 4 U/ml penicillin, and 4 g/ml
streptomycin. wt and mutated proteins were expressed using a vaccinia virus-T7
(vTF7-3) RNA polymerase expression system, which drives expression of genes
under the control of the T7 promoter in pBSK (16). Transfections were per-
formed by a modification of previously described methods (29). Briefly, cells
were seeded in six-well plates at 3.5  105 per well 1 day prior to transfection.
The monolayers were infected with vTF7-3 at a multiplicity of infection of 0.5
and incubated for 1 h at 37°C. The cells were transfected with 0.5 g of each
DNA complexed with dimethyldioctadecylammonium bromide (DDAB) in
OptiMEM. After a 5-h incubation at 37°C, cell maintenance medium was added
to each well and the cells were returned to 37°C for at least 20 h. For co-IP
assays, cells were seeded at 3  105 per well, DMEM was added immediately
following addition of the DNA-DDAB complexes, and the transfected cells were
incubated for a maximum of 16 h at 37°C.
Quantitation of cell surface MV H. Flow cytometric analysis was used to
quantitate cell surface expression as previously described (29). Anti-MV H
hybridoma supernatant was harvested from B2 cells. Transfected HeLa mono-
layers were washed twice with PBS-FCS (phosphate-buffered saline [PBS] con-
taining 5% FCS) and then incubated at room temperature for 30 min with
hybridoma supernatant. The cells were washed twice with PBS-FCS and then
incubated with a 1:200 dilution of fluorescein isothiocyanate conjugated to either
goat anti-mouse immunoglobulin G or goat anti-rabbit immunoglobulin G in
PBS-FCS for 30 min. After two additional washes with PBS-FCS, the monolayers
were detached with 0.0625 mM EDTA in PBS, pelleted by centrifugation, and
washed once with PBS-FCS. The cells were fixed in PBS with 1% FCS plus 1%
paraformaldehyde prior to analysis. Expression level is presented as mean fluo-
rescent intensity minus background labeling of control cells transfected with
vector alone.
HAd assay. HAd activity of transfected HeLa cells was determined by mea-
suring the ability of the expressed MV H protein to adsorb African green monkey
(AGM) erythrocytes via CD46 (18) (Three Springs Scientific, Inc., Perkasie, PA)
by use of a modification of a previously described protocol (8). These assays were
performed at 37°C to reduce nonspecific binding of the erythrocytes to the
monolayers. MV H-expressing monolayers were incubated for 30 min with a 2%
suspension of erythrocytes in prewarmed PBS supplemented with 1% CaCl2 and
1% MgCl2 (PBS). Monolayers were washed with warm PBS and then incu-
bated for an additional 10 min at 37°C to allow release of nonspecifically bound
erythrocytes. The cells were washed with warm PBS, and then adsorbed eryth-
rocytes were lysed in 50 mM NH4Cl. Lysates were cleared by centrifugation, and
absorbance was quantified at 540 nm with a Spectra Max 250 microplate spec-
trophotometer (Molecular Devices, Sunnyvale, CA), with background obtained
with cells expressing vector alone subtracted.
Content-mixing assay for fusion. The abilities of H and F proteins to promote
fusion were quantitated using a modification of the content-mixing assay de-
scribed by Nussbaum et al. (31) and Bagai and Lamb (2). Monolayers of HeLa
effector cells were infected with vTF7-3 and cotransfected with H and a trypsin-
activated cleavage site mutant form of F (Fcsm). Fcsm was created by mutating
the cleavage site from RRHKR to RNHNR, as described by Maisner et al. (25).
Monolayers of HeLa target cells were infected with wt vaccinia at a multiplicity
of infection of 10 and transfected with 1 g per well of plasmid pGINT7-gal,
which carries the -galactosidase gene under the control of a T7 promoter.
At 20 to 22 h posttransfection, cells were removed from the wells by treatment
with 0.05% trypsin and 0.53 mM EDTA (Gibco) and washed with DMEM. The
two cell populations were combined in replicate wells of a 96-well microtiter
plate at an effector-to-target ratio of 2:1. Cells were incubated at 37°C for 5 h and
then lysed for at least 30 min with 10 l of 10% IGEPAL CA-630 (Sigma). Then,
50 l of the lysate was mixed with 20 l of the -galactosidase substrate 16 mM
chlorophenol red--D-galactopyranoside and incubated briefly at room temper-
ature. The extent of fusion was quantitated by determination of the absorbance
at 590 nm with a Spectra Max 250 microplate spectrophotometer, with back-
ground obtained with cells expressing MV Fcsm alone subtracted.
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Lipid-mixing assay. The abilities of MV H and F mutants to promote lipid
mixing were assessed by the transfer of octadecyl rhodamine b chloride (R18;
Invitrogen) from AGM erythrocytes to HeLa cells cotransfected with MV H and
F genes, using a modification of a protocol described by Morris et al. (30).
Freshly labeled erythrocytes were prepared just prior to each experiment. Briefly,
to label the erythrocytes, 20 ml of a 2% suspension was incubated with 30 l of
100 M R18 in ethanol in cold PBS for 15 min in the dark at room temper-
ature. Unbound R18 was removed by the addition of 30 ml DMEM with 5% FCS
and an additional 15-min incubation. The erythrocytes were washed three times
with DMEM with 5% FCS and twice with PBS followed by resuspension in 20
ml PBS.
Lipid-mixing assays were performed using HeLa cells at 18 h posttransfection
with the MV H and F genes. For each assay, R18-labeled erythrocytes were
added to each monolayer of transfected HeLa cells. After incubation for 30 min
on ice in the dark to allow erythrocyte binding by MV H, fusion between the cell
monolayers and erythrocytes was initiated by transferring cells to 37°C. After the
desired amount of time, the cell monolayers were washed with warm PBS to
remove unbound erythrocytes. Images were acquired immediately with a 20
objective by using fluorescent microscopy and OPEN Lab software (Improvision,
Inc., Cambridge, MA).
co-IP. The abilities of wt and mutated MV H proteins to co-IP with MV Fcsm
were assayed using a modification of protocols of Yao et al. (50) and Deng et al. (8).
At 16 h posttransfection, cells were starved for 1 h at 37°C in DMEM lacking
cysteine and methionine. The cells were then labeled for 5 h at 37°C with 100 Ci/ml
of Expre35S35S-cysteine-methionine labeling mix (Dupont-New England Nuclear,
Boston, MA). Then, the cells were washed three times and incubated for 30 min on
ice with cold PBS-CM (PBS supplemented with 0.1 mM CaCl2 and 1 mM MgCl2).
Cell surface proteins were biotinylated with sulfo-NHS-SS-biotin (Pierce, Rockford,
IL) dissolved in cold PBS-CM for 30 min on ice with gentle agitation. Excess
biotinylating reagent was removed with PBS-CM washes, and then the labeled cells
were lysed with 0.4 ml DH lysis buffer (50 mM HEPES, pH 7.3 [United States
Biochemical, Cleveland, OH], 10 mM lauryl maltoside [United States Biochemical],
150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride) for 45 min on ice.
Lysates from three wells of a six-well plate were combined and split into two equal
aliquots into tubes containing the appropriate antibodies (either Fcyt alone or Fcyt
plus anti-H MAbs). The immunoprecipitation reaction mixtures were incubated for
90 min at 4°C and then cleared by centrifugation. Antigen-antibody complexes were
collected from the supernatants with bovine serum albumin-blocked Immunopure
immobilized protein G beads for 1 h at 4°C and then washed with DH lysis buffer.
The protein-bead complexes were boiled for 5 min in 10 l of 10% sodium dodecyl
sulfate (SDS), and the released proteins were resuspended in DH lysis buffer. The
protein G beads were removed by centrifugation, and then the supernatants were
incubated with immobilized streptavidin beads (Pierce) overnight at 4°C. The beads
were washed twice with DH lysis buffer and then resuspended in reducing buffer for
analysis by SDS-polyacrylamide gel electrophoresis. The percentage of total cell
surface H coimmunoprecipitated with F was quantified using a Bio-Rad Fluor-S
multi-imager (Hercules, CA).
RESULTS
Alanine-scanning mutagenesis of residues 244 to 250 in MV
H: cell surface expression and functional characteristics. As
shown in Fig. 1, residues 244 to 250 are located in the ectodo-
main of MV H. This region has been proposed to form the
“topographical or functional interface” between MV H and F
(15). With the goal of characterizing the roles of these residues
in the fusion-related functions of MV H, including the receptor
recognition and fusion helper activities, proteins carrying ala-
nine substitutions for residues S244, E245, L246, S247, Q248,
L249, S250, S244/L246, and S244/E245 were prepared and
characterized (Fig. 1).
The cell surface expression of each mutated protein was
quantitated by flow cytometry with an MAb that recognizes the
ectodomain of MV H. As shown in Fig. 2, all of the mutated
proteins were detected at the cell surface at levels similar to
that of wt MV H, ranging from 92 to 111% of the wt expression
FIG. 1. Diagram of MV H structure, including the amino acid sequences of the HR-like region (residues 84 to 105) and region 244 to 250.
Individual mutations introduced into these regions are listed beneath the wt sequence. tm, transmembrane; C139 and C154, cysteines 139 and 154
involved in intermonomer disulfide bonds.
FIG. 2. Cell surface expression (CSE) and functional characteris-
tics of the MV H proteins with alanine substitutions in region 244 to
250. CSE was quantitated by flow cytometry with MAbs specific for
antigenic sites in the ectodomain of the protein. HAd activity was
quantitated by the ability of the transfected HeLa cells to adsorb AGM
erythrocytes. The abilities of the mutated H proteins to complement
MV Fcsm in the promotion of membrane fusion were determined by
a content-mixing assay. For each assay, the background detected in
cells transfected with vector has been subtracted. All data points rep-
resent the means of at least three independent experiments and are
expressed relative to the activities of the wt proteins.
9902 COREY AND IORIO J. VIROL.
 at UNIV O
F M
ASS M
ED SCH on Decem






level. The receptor-binding activities of the proteins were eval-
uated by assaying their abilities to adsorb AGM erythrocytes.
HAd levels ranged from 88% for L249A to 107% for S250A.
Additionally, the ability of mutated MV H proteins to promote
membrane fusion with the homologous F protein was quanti-
tated using a content-mixing assay. All of the mutated proteins
promote cell-to-cell fusion at levels similar to that of wt MV H,
ranging from 80 to 95% of the wt level.
Two additional proteins carrying double alanine substitutions,
S244A/L246A and S244A/E245A, were prepared and character-
ized. The rationale for these choices was the fact that the alanine
mutations at positions 244 and 246 exhibited the lowest levels of
fusion, albeit only slightly, and that, in early experiments, the
E245A mutation exhibited the third-lowest level of fusion. How-
ever, both sets of double mutations resulted in levels of fusion
similar to that of the wt H protein (95% and 88% of wt activity,
respectively). Similar results were obtained for cell surface expres-
sion and receptor binding. Thus, contrary to previous predictions
(15), these results suggest that no residue in this region has a
significant role in the receptor-binding activity or fusion promo-
tion activity of MV H.
Mutation of an HR-like domain in the stalk of MV H: cell
surface expression and functional characteristics of MV H
proteins carrying mutations for the heptadic residues. Exam-
ination of the sequence of the MV H stalk reveals an HR-like
domain spanning the region I84 to L105 (Fig. 1). As shown in
Fig. 3, alignment of the MV H stalk sequence with those of
other paramyxoviruses reveals that, within the family, there is
positional conservation of these domains. Although the HR-
like domains are not conserved with respect to length or num-
ber of repeats, there is a striking conservation of 2 residues
near the middle of each region: a proline that is completely
conserved, as well as a leucine that is conserved in type. These
residues are located between the second and third heptadic
residues in the domain at positions 94 and 95, though the PL
motif is not positionally conserved relative to the HRs between
family members.
The roles of the heptadic residues (I84, V91, I98, and L105)
in the fusion process were examined by the introduction of an
alanine substitution at each of these positions in the MV H
protein and by characterization of the mutated proteins. Based
on the results of Hummel and Bellini (20), an additional pro-
tein with an I98T substitution was tested.
Initially, the abilities of MV H proteins with amino acid
substitutions at the heptadic positions to complement MV F in
fusion promotion were quantitated. H proteins carrying the
I84A, I98A, I98T, and L105A mutations exhibit significantly
reduced fusion promotion activities of 0%, 0.7%, 5%, and 47%
of the activity of wt H, respectively (Fig. 4). The V91A muta-
tion results in only a very slight reduction in fusion promotion
(94% that of wt H). The reduction in fusion promotion by the
mutated proteins cannot be attributed to reduced cell surface
expression, which ranges from 90 to 108% of the wt level for
these proteins (Fig. 4).
To determine if the basis for the reduced fusion promotion
by the mutated proteins is a decreased ability to recognize
receptors, HAd activity was quantitated. Only one of the four
mutated proteins with deficiencies in membrane fusion pro-
motion, the I84A-mutated protein, also has significantly re-
duced HAd activity (34% that of wt H). Thus, the reduced
fusion promotion exhibited by the I84A-mutated protein
seems to correlate with an alteration in the structure and/or
orientation of the globular head domain. The other proteins,
carrying the I98A, I98T, and L105A mutations, have HAd
activities ranging from 82 to 108% of wt H activity, indicating
that the fusion deficiency of these mutated proteins is not a
result of decreased recognition of receptors. Importantly, the
phenotype of the H protein carrying the I98T mutation is
consistent with the results of Hummel and Bellini (20), and an
I98A-mutated protein exhibits similar properties.
Cell surface expression and functional characteristics of
MV H proteins carrying mutations at nonheptadic positions in
the HR-like domain. To further probe the role of the HR-like
region in fusion promotion, MV H proteins with a P94A, -G, -L,
or -S substitution, as well as those with an L95A, -P, or -R sub-
stitution, were prepared and characterized. The remaining resi-
dues between the second and third heptadic hydrophobic residues
were also each individually replaced with alanine residues. Thus,
FIG. 3. Comparison of the amino acid sequences in the HR-like
domains in the stalks of various paramyxovirus attachment glycopro-
teins. The numbers (1 to 4) above the sequences indicate the heptadic
residues, which are also in bold print. The highly conserved proline and
leucine residues are indicated in large print. The sequences and rele-
vant references are as follows: MV (1), CDV (21), NDV (26), hPIV3
(12), and mumps virus (MuV) (46).
FIG. 4. Cell surface expression (CSE) and functional characteris-
tics of the MV H proteins with mutations in the heptadic residues of
the HR-like domain. Assays were performed as described in the legend
to Fig. 2. All data points represent the means of at least three inde-
pendent experiments and are expressed relative to the activities of the
wt proteins.
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individual mutated proteins, carrying an L92A, T93A, F96A, or
K97A substitution, were constructed. Two additional mutations,
F96L and I99A, were also evaluated.
As shown in Fig. 5, H proteins carrying individual P94A, -G,
-L, and -S mutations exhibit fusion promotion activities of 3%,
0%, 2.8%, and 7.9%, respectively, of the level of wt H activity.
While each of the mutated proteins has a cell surface expres-
sion level similar to that of wt H, ranging from 95% to 102%,
the HAd activities of the proteins are significantly reduced to
levels of 36%, 36%, 44%, and 48% of wt H levels, respectively.
These results suggest that amino acid substitutions at P94 alter
the structure and/or orientation of the globular head domain,
in which the receptor-binding activity resides.
MV H proteins with amino acid substitutions at L95 were also
tested for the ability to complement MV F in fusion promotion
(Fig. 5). Each of the mutated proteins exhibits a significant defi-
ciency in the ability to promote membrane fusion, with activities
ranging from 0.5% to 32% of the wt H level. Each of the proteins
carrying a substitution at L95 was expressed at the cell surface at
a level similar to that of wt H (95% to 109% of the wt level).
While L95A and -R mutations do not significantly decrease re-
ceptor recognition by MV H, the mutation of L95 to proline
strongly reduces it to a level of 34% of wt H. These results suggest
that the identity of the amino acid at position 95 may play a role
in fusion promotion. However, it appears that the drastic proline
mutation may alter the structure and/or orientation of the glob-
ular domain of MV H.
Alanine substitutions at the remaining positions between the
second and third heptadic residues of the HR-like domain,
including L92, T93, F96, and K97, were tested for their effect
on the functions of MV H. Subsequently, F96 was also mutated
to leucine. Another mutation, I99A, which is located between
the third and fourth heptadic residues, was also characterized.
Each of the mutated proteins is expressed at the cell surface at
a level similar to that of wt H, ranging from 86% to 100% of
the wt level (Fig. 6). All but one of these mutations, T93A,
significantly decrease fusion promotion. Two of the amino acid
substitutions, L92A and I99A, also decrease receptor recogni-
tion to 34% and 38% of the wt level, respectively. Substitutions
at the two remaining residues, F96 and K97, result in signifi-
cant deficiencies in fusion promotion not attributable to cor-
responding reductions in receptor recognition. Together with
the data obtained for the conserved P94 and L95 residues,
these results suggest that the nonheptadic residues in the HR
domain in the stalk of MV H are important for both the
structure and fusion promotion functions of H.
Comparison of HAd versus fusion promotion activity segre-
gates amino acid substitutions in the MV H HR into three
groups. A plot of HAd versus fusion promotion activity of MV
H proteins carrying amino acid substitutions in the HR-like
domain reveals that the mutated proteins can be divided into
three groups based on their functional activities (Fig. 7). The
first group (V91A and T93A) includes amino acid substitutions
that do not significantly alter either receptor recognition or
fusion promotion. The second group (I84A, L92A, P94A, etc.)
is characterized by strong deficiencies in both receptor binding
and fusion promotion. The third group (L95A, F96A, I98A,
etc.) exhibits significant deficiencies in fusion promotion activ-
ities not attributable to diminished receptor-binding activity.
All of the MV H proteins carrying mutations in the HR-like
FIG. 5. Cell surface expression (CSE) and functional characteris-
tics of the MV H proteins with mutations at P94 and L95 in the
HR-like domain. Assays were performed as described in the legend to
Fig. 2. All data points represent the means of at least three indepen-
dent experiments and are expressed relative to the activities of the wt
proteins.
FIG. 6. Cell surface expression (CSE) and functional characteris-
tics of the MV H proteins with mutations within the IRs of the HR-like
domain. Assays were performed as described in the legend to Fig. 2.
All data points represent the means of at least three independent
experiments and are expressed relative to the activities of the wt
proteins.
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domain have cell surface expression levels similar to that of wt
H. Additionally, representative proteins from each group dis-
played sucrose sedimentation profiles similar to that of wt H,
with the majority sedimenting as a tetramer but with a smaller
amount of dimer also present (data not shown).
Detection of an interaction between MV H and F at the cell
surface. If MV H and F interact during the promotion of
fusion, it should be possible to co-IP the two proteins from the
surface of infected cells with an antibody to only one of them.
As the MV H and F proteins are expressed and functional in
HeLa cells, these cells were used to develop a co-IP assay to
look for an interaction between the proteins at the cell surface.
For this assay, Fcsm, which requires the addition of exogenous
trypsin for activation, was used in order to prevent comparison
of fusing and nonfusing monolayers. The method used for
co-IP is analogous to that used in our laboratory for studies of
NDV glycoprotein interactions (8, 27, 28). Figure 8 shows that
the two glycosylation isoforms of MV H, with apparent molec-
ular sizes of 74 and 78 kDa (32, 33), are coimmunoprecipitated
with Fcsm. This demonstrates the detection of the formation of
a complex between MV H and F at the cell surface. Approx-
imately 21% (9%) of the total amount of MV H can be
coimmunoprecipitated with Fcsm by using Fcyt antibody.
Figure 8 also shows critical controls. The first lane for each
pair shows the maximum amounts of the two proteins that can
be immunoprecipitated from the cell surface for each sample.
The first pair of lanes shows that neither protein is present in
control cells transfected with empty vector. The second pair of
lanes demonstrates that MV H does not immunoprecipitate
with the F antiserum in the absence of the F protein, and the
third pair shows that the protein that co-IPs with F is not
present in cells that have not been transfected with the MV H
gene. These controls establish the specificity of the co-IP of H
by the anti-F antibody.
Amino acid substitutions in the HR domain of MV H do not
prevent formation of the complex with F at the cell surface.
Mutations in the intervening region (IR) between the repeats
in the stalk of the NDV HN protein have been shown to
modulate fusion and interfere with formation of the HN-F
complex at the cell surface (28). In order to investigate this as
a possible explanation for the phenotypes of the MV H pro-
teins carrying point mutations in this domain, several of the
mutated proteins were tested for the ability to interact with
MV F at the cell surface.
Figure 9A shows the results of a co-IP assay for each of the
proteins carrying alanine substitutions for the heptadic hydro-
phobic residues: I84, V91, I98, and L105. Despite the signifi-
cant deficiencies in receptor binding and/or fusion promotion
associated with three of the four mutations, each of the mu-
tated proteins efficiently co-IPs with MV F. Indeed, for these
mutated proteins, there seems to be an inverse relationship
between the extent of fusion and the extent of co-IP (Table 1).
I84A-mutated H, which fails to promote detectable fusion,
co-IPs three times more efficiently than wt H; I98A-mutated H,
for which fusion is barely detectable (1% of the wt level),
co-IPs twice as efficiently as wt H. Moreover, L105A-mutated
H fuses approximately half as efficiently yet co-IPs two-thirds
more efficiently than the wt protein, whereas V91A-mutated H
FIG. 7. Correlation of ability to promote fusion with HAd activity
of MV H proteins with mutations in the HR-like domain in the stalk.
Based on this plot, the mutated proteins can be divided into three
groups: (1) no significant deficiencies in receptor binding or fusion
promotion, (2) significant deficiencies in both activities, and (3) signif-
icant deficiencies in fusion promotion but not receptor binding.
FIG. 8. Detection of formation of a complex of wt MV H and Fcsm at the surface of HeLa cells by using a co-IP assay. The surface proteins
of transfected cells were biotinylated, and then the cells were lysed with lauryl maltoside. The lysates were split into two equal aliquots and
subjected to the co-IP protocol by using a mixture of two MAbs against the H protein and a polyclonal antiserum against the cytoplasmic tail of
F (the first lane in each pair) or the F antiserum alone (the second lane in each pair). Immunoprecipitates were displayed on reducing
SDS-polyacrylamide gels.
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both fuses and co-IPs at levels similar to wt levels. Thus, com-
plete or near-complete elimination of the fusion-promoting
activity of MV H, resulting from mutations for heptadic resi-
dues in the HR-like domain in its stalk, does not eliminate the
ability of the H protein to interact with the homologous F
protein at the cell surface; on the contrary, it seems to stabilize
the H-F interaction. It is also interesting to note that there is
variability in the amounts of the 78-kDa protein that co-IP with
F for each of these mutated proteins (Fig. 9). However, this
variability does not appear to correlate with functional defi-
ciencies in either receptor binding or membrane fusion pro-
motion.
To determine if the deficiencies in receptor recognition and
fusion promotion by mutated proteins carrying substitutions at
the conserved P94 and L95 residues correlate with an inability
to interact with MV F at the cell surface, the abilities of P94S-
and L95A-mutated H, each of which promotes fusion at less
than 20% of the wt level, to co-IP with MV F were determined.
As shown in Fig. 9B, both of the mutated proteins retained the
ability to co-IP with MV F, despite their drastic loss of fusion-
promoting activity. P94S- and L95A-mutated H, which fuse at
8 and 16% of the wt level (Fig. 5), co-IP about as efficiently as
wt H, i.e., 114.5% and 93.4%, respectively (Table 1). Thus, the
apparent specific loss of fusion helper function resulting from
the L95A mutation (no significant effect on HAd) (Fig. 5) is
not due to an effect on the ability of H to interact with F.
Interestingly, the inverse relationship between fusion and
co-IP exhibited by the group of heptadic mutations is not
manifested by these two mutations.
Mutated proteins carrying amino acid substitutions at the
remaining residues between the second and third heptadic
residues of the domain, as well as a protein with a substitution
at the first amino acid between the third and fourth heptadic
residues, were also tested for the ability to interact with MV F
at the cell surface. Similarly to the above-mentioned results,
each of the mutated proteins, including L92A and T93A (Fig.
10A), as well as F96L, F96A, K97A, and I99A (Fig. 10B), can
be coimmunoprecipitated efficiently with MV F at the cell
FIG. 9. Detection of formation of complexes between MV H mutants with MV Fcsm at the cell surface. (A) Co-IP of MV H proteins carrying
mutations in the heptadic residues with MV F. (B) Co-IP of MV H proteins carrying mutations at P94 and L95 with MV F.
TABLE 1. Percent co-IP of mutated H proteins compared to their
HAd and fusion-promoting activities
Mutation Groupa % wt HAd % wt fusion % wt co-IPb
V91A 1 92.8 94.4 119
T93A 1 100.7 73.1 140
I84A 2 34.1 0 299
L92A 2 33.5 0 180
P94S 2 48.0 7.9 115
I99A 2 38.2 0 141
L95A 3 93.6 15.5 93
F96A 3 82.2 3.5 65
F96L 3 89.4 12.8 125
K97A 3 76.9 10.3 109
I98A 3 90.4 0.7 200
L105A 3 81.9 47.3 168
a From Fig. 7.
b Percentage of total mutated H that co-IPs with antibody to F divided by
percentage of wt H that co-IPs, multiplied by 100.
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surface. Again, as for the mutated proteins with results shown in
Fig. 9A, those with no detectable fusion, L92A- and I99A-mu-
tated H, exhibited increased co-IP (180% and 141%, respectively)
relative to that of the wt protein (Table 1). F96A-, F96L-, and
K97A-mutated proteins, which exhibit comparatively minimal fu-
sion-promoting activities, ranging from 3.5% to 12.8% that of the
wt, co-IP at levels similar to or less than that of wt H (65%, 125%,
and 109%, respectively). The T93A-mutated protein fuses at
73.1% of the wt level and co-IPs at 140% of the wt level.
Taken together, the results of these co-IP assays indicate
that individual amino acid substitutions in the HR-like domain,
some of which drastically reduce or even eliminate fusion, do
not prevent formation of the MV H-F complex at the cell
surface. An interaction at the cell surface between H and F can
be detected for mutated H proteins from all three groups
identified in Fig. 7. On the contrary, the data indicate that a
complete loss of fusion-promoting activity correlates with a
stabilization of the H-F complex at the cell surface.
The HR domain is not the sole determinant of the specificity
of the MV H-F interaction. Alignment of the MV and CDV H
sequences reveals that there are four residues that differ be-
tween the proteins in the HR domain (Fig. 3). These differ-
ences are at positions 84, 85, 89, and 103. In order to determine
if the HR domain mediates the specificity of the interaction
between H and F, these sites were mutated in MV H to the
corresponding residues of CDV H. An MV H protein carrying
all of the mutations I84V, E85H, K89I, and V103I was pre-
pared and characterized. The mutated protein promotes mem-
brane fusion at approximately 55% of the extent of wt H
activity. The reduction in fusion activity does not correspond to
a decrease in cell surface expression (107% that of wt H) or
receptor binding (99% that of wt H). The mutated protein is
unable to promote fusion when coexpressed with CDV F (0%
wt MV H-F fusion activity). These data are consistent with the
results of the co-IP assays, indicating that the MV H HR-like
domain is not the sole mediator of the specific physical asso-
ciation between H and F at the cell surface that is required for
fusion promotion.
Amino acid substitutions in the HR-like domain of MV H
that abolish fusion also abolish lipid mixing. It is thought that,
during the membrane fusion process, activation of F and insertion
of the fusion peptide into the target membrane initially lead to
merger of the lipid bilayers, often called hemifusion, before fusion
pore formation and content mixing. Mutation of the conserved
proline, P111, between the HRs in the stalk of the human para-
influenza virus 3 (hPIV3) attachment protein does not alter re-
ceptor binding but has been found to decrease the rate of trig-
gering of the F protein into its activated form (38). Insertion of
the fusion peptide into the target membrane and lipid mixing
were shown to occur, but more slowly than when F was triggered
by wt HN-expressing cells. A lipid-mixing assay with R18-labeled
erythrocytes was used to determine if this is also the case for the
MV H proteins carrying mutations in the HR that abolished
fusion without altering receptor binding.
Figure 11 shows the results of a lipid-mixing assay performed
with wt MV F coexpressed with the H proteins carrying sub-
stitutions P94A, L95A, I98A, and I98T, each of which drasti-
cally decreases fusion. The controls for this experiment show
that there is dye transfer from the labeled erythrocytes to cells
expressing wt H and F, but not when H is expressed with Fcsm.
As expected, based on its defect in receptor binding, the P94A-
mutated H protein does not trigger lipid mixing. Despite de-
FIG. 10. Co-IP of MV H proteins carrying mutations in the IR with MV F. (A) Co-IP of L92A- and T93A-mutated proteins. (B) Co-IP of
proteins carrying a mutation at position 96, 97, or 99. The experiments were performed as described in the legend to Fig. 8.
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tectable HAd of the labeled red blood cells, dye transfer is not
detectable for the remaining mutants tested with this assay.
These results suggest that membrane fusion promotion by
these mutated proteins is blocked before MV H triggers F
activation to initiate insertion of the fusion peptide into the
target membrane.
DISCUSSION
Identification of the domains of the paramyxovirus attach-
ment and fusion proteins that mediate the interaction between
them necessary for fusion is an important part of understand-
ing the mechanism of membrane fusion. Two regions of MV H
have been proposed to mediate its fusion helper function, one,
including residue I98, in the stalk and another, including res-
idues 244 to 250, in the head (15, 17, 20). Despite the potential
importance of these regions of the H and F proteins in fusion
promotion, their role in fusion has not been established.
The contention that region 244 to 250 in MV H constitutes
the F-interactive domain is based on its recognition by an MAb
that inhibits membrane fusion without altering receptor rec-
ognition activity (13, 15). However, the involvement of these
residues in fusion promotion was not tested directly. The re-
sults of alanine-scanning mutagenesis of the residues in this
region and characterization of the mutated proteins suggest
that no single residue in this region is critical for either recep-
tor binding or fusion promotion.
Region 244 to 250 is positioned on the model of MV H in a
loop that protrudes into the putative center of symmetry of the
tetramer (10). It is possible that antibodies directed against this
region may inhibit fusion by interfering with the stability of the
H tetramer. Antibody binding in this region could also inhibit
membrane fusion indirectly by interfering with conformational
changes in H that take place after receptor binding or by
sterically blocking a nearby region.
Chimera and mutagenesis studies of the attachment proteins
of other paramyxoviruses suggest that the stalk region both
determines the specificity of the HN-F interaction and directly
mediates it (7–9, 27, 28, 42, 43). Site-directed mutagenesis of
individual residues within the stalk has identified specific
amino acids involved in the interaction with F, in the process
identifying a region that may contribute to the F-interactive
domain (28, 39). These residues are located in domains known
as HRs (38), though they do not completely fulfill the require-
ments of that motif. In most paramyxoviruses, the HR-like
domain in the attachment protein stalk consists of two motifs
separated by an IR containing a highly conserved proline-
leucine doublet. Unlike those of most other paramyxoviruses,
the morbillivirus attachment proteins have 6 residues in the
analogous region, such that the entire domain constitutes a
single, more extended HR-like domain, albeit with a helix-
disrupting or kink-forming proline in the middle. A similar
motif containing an LXP domain has been described previ-
ously for the MV F protein (35).
Through construction and testing of MV H chimeras for
fusion promotion, an amino acid difference at position 98,
which is located at a core position in the HR-like domain, was
found to be responsible for the lack of fusion in a persistently
infected cell line (20). While it was demonstrated that this
residue is critical for fusion promotion, it was not determined
if mutation of it affects receptor recognition activity. Although
it is located in the stalk, the mutation could conceivably alter
the conformation of the regions of the globular domain that
are responsible for receptor binding. Indeed, substitutions for
some of the individual heptadic hydrophobic residues in NDV
HN, as well as residues in the IR between them, diminish
fusion promotion but also alter receptor recognition and neur-
aminidase activity (28, 41, 45).
Here, we have confirmed that alanine and threonine substi-
tutions for I98 strongly decrease fusion with no significant
effect on either surface expression or receptor binding, consis-
tent with the idea that the residue is involved in the fusion
helper function of MV H, as originally proposed by Hummel
and Bellini (20). However, while the I98A mutation disrupts
fusion promotion at a stage prior to the triggering of MV F, it
does not abolish the H-F interaction at the cell surface. On the
contrary, it seems to stabilize it.
Indeed, we have performed an extensive site-directed muta-
tional analysis of the role in fusion of several residues in the
HR-like domain in the stalk of MV H. Our results show that,
although many mutations in this region severely decrease, even
FIG. 11. Promotion of lipid mixing by MV H proteins with muta-
tions in the HR-like domain. The extent of lipid mixing is shown by the
spread of the dye from R18-labeled AGM erythrocytes into the cell
membranes of transfected HeLa cells. Labeled erythrocytes were
added to each monolayer, and then the cells were incubated on ice for
30 min. Fusion between the transfected cells and erythrocytes was
initiated by transferring the cells to 37°C. After 30 min, the cells were
washed, and then images were acquired immediately with a 20 ob-
jective by using fluorescent microscopy.
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eliminate, fusion, none of them results in a decrease in the
amount of H that co-IPs with F commensurate with the de-
crease in fusion (Table 1). When the percentage of each mu-
tated H protein that co-IPs with F is examined relative to its
HAd and fusion-promoting activities (Table 1), a correlation
between complete loss of fusion and increased co-IP becomes
apparent. All three group 2 mutations that completely elimi-
nate fusion (I84A, L92A, and I99A) stabilize the H-F complex
at the cell surface. I84A- and L92A-mutated H co-IP almost
300% and 180% compared to wt levels, respectively. While the
increased co-IP could be related to the reduced HAd activities
of these proteins, I98A-mutated H (group 3), which fuses at
1% of the wt level but has HAd activity near that of the wt,
co-IPs twofold better than the wt. These findings are consistent
with previous results demonstrating that the extent of MV
fusion is inversely related to the strength of the interaction
between the H and F proteins (37).
However, this inverse relationship is really demonstrated only
by those mutated proteins that exhibit1% of wt fusion. Mutated
proteins that fuse at 7.9 to 15.5% of the wt level, e.g., P94S, L95A,
F96L, and K97A, co-IP about as well as the wt protein (93 to
125%). With the exception of P94S-mutated H, these all fall in
group 3, comprised of proteins that exhibit markedly decreased
fusion despite essentially wt HAd activity. It is also noteworthy
that these mutations lie in a linear 4-amino-acid sequence in the
region. Although they show markedly decreased fusion-promot-
ing activity, they do not co-IP more efficiently than the wt protein.
Thus, it seems more likely that these mutations could directly
affect the interaction with the F protein and that the domain
could directly contribute to it.
However, if this is the case, one must be able to rationalize
the ability of these mutated proteins to still form the complex
with F but not promote fusion. This can be accounted for in at
least two ways. First, it is possible that residues 94 to 97 are
part of the only domain in H that interacts with F and that
mutation of a single amino acid in it is insufficient to prevent
formation of the complex with F. Second, multiple regions of
MV H may be involved in the formation of the H-F complex
and the mutations in the linear domain spanning residues 94 to
97 do not disrupt its ability to interact with F, though they do
impair fusion. In either case, the H-F complex could be of low
enough avidity that it is incapable of resulting in fusion. In this
regard, it should be noted that the co-IP assay is designed to
maximize capture of the H-F complex and, as such, could
detect a low-avidity association between the two proteins.
Whatever the basis for the co-IP findings with the MV H
mutated proteins, one thing is clear. These findings are in
direct contrast to the findings with NDV, where several anal-
ogous HN mutations, which result in significant though less
drastic fusion deficiencies, reduce the HN-F complex to an
undetectable level (28). The differential effects of mutations in
the HR-like domain in MV H and NDV HN on the glycopro-
tein interaction are consistent with the fusion activation of the
F protein in the two viruses being regulated by different mech-
anisms. This, in turn, is consistent with the idea, originally
proposed by Plemper et al. (36), of a differential mechanism
for regulation of the fusion activation of F in viruses that
recognize the abundant sialic acid moiety, e.g., NDV, hPIV3,
and simian virus 5, and those, such as MV, that recognize
specific receptors.
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